Dr Steven Raymond Pezzullo, MD | |
982 Tiogue Ave, Coventry, RI 02816-6167 | |
(401) 821-6800 | |
(401) 821-8513 |
Full Name | Dr Steven Raymond Pezzullo |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 982 Tiogue Ave, Coventry, Rhode Island |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336385350 | NPI | - | NPPES |
1336385350 | Other | BLUE CROSS | |
7003151 | Medicaid | RI | |
1336385350 | Other | UNITED HEALTHCARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 5845 (Rhode Island) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Steven Raymond Pezzullo, MD 982 Tiogue Ave, Coventry, RI 02816-6167 Ph: (401) 821-6800 | Dr Steven Raymond Pezzullo, MD 982 Tiogue Ave, Coventry, RI 02816-6167 Ph: (401) 821-6800 |
News Archive
Researchers at the University of Pennsylvania School of Medicine report how the gene for utrophin, which codes for a protein very similar to dystrophin, the defective protein in Duchenne muscular dystrophy (DMD), puts the brakes on its own expression in muscle cells, thereby suggesting a new target for treatment.
Children's Hospital Colorado has announced that its Mike McMorris Cystic Fibrosis Research and Care Center, one of the largest cystic fibrosis clinical care centers in the U.S., is participating in one of two Phase Three clinical trials related to the development of a possible breakthrough therapy for people with CF.
In an editorial entitled "The Unmet Promise of a Miracle Drug for Alzheimer's Disease: Implications for Practice, Policy, and Research," Malaz Boustani, MD, MPH, a Regenstrief Institute research scientist and the founding director of the Indiana University Center for Health Innovation and Implementation Science, and co-authors Philip D. Sloane, MD, MPH and Sheryl Zimmerman, PhD, of the University of North Carolina at Chapel Hill, lament the unmet promise of a miracle drug for Alzheimer disease but are heartened by what they see as encouraging improvements in care for a growing population of older adults, many with dementia.
Italian scientists announced (Monday September 24) that they have found a new and promising target for anti-tumour therapy in cancer.
Providing a standing desk to every primary school child in a UK classroom can reduce sitting time throughout most of the academic year, according to a new study.
› Verified 5 days ago